Inhibitors of Histon Deacetylase (HDAC) and DNA Methyltransferase in Treatment Children With Acute Myeloid Leukemia, Effectiveness and Place

Russian Journal of Children Hematology and Oncology
doi 10.17650/2311-1267-2016-3-4-48-54
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OOO Grafika

Related search

FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia

Cancer
Cancer ResearchOncology
2011English

CDK9 Inhibitors in Acute Myeloid Leukemia

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2018English

High DNA Methyltransferase DNMT3B Levels: A Poor Prognostic Marker in Acute Myeloid Leukemia

PLoS ONE
Multidisciplinary
2012English

Life-Threatening and Fatal Infections in Children With Acute Myeloid Leukemia

Journal of Pediatric Hematology/Oncology
Child HealthOncologyPediatricsHematologyPerinatology
2012English

Targeting DNA Hypermethylation: Computational Modeling of DNA Demethylation Treatment of Acute Myeloid Leukemia

Epigenetics
Cancer ResearchMedicineMolecular Biology
2017English

A Regimen Combining the Wee1 Inhibitor AZD1775 With HDAC Inhibitors Targets Human Acute Myeloid Leukemia Cells Harboring Various Genetic Mutations

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2014English

Treatment Patterns and Outcomes of Octogenarian Patients With Acute Myeloid Leukemia

American Journal of Hematology
Hematology
2019English

Six (Or More) Drugs in Search of a Mechanism: DNA Methyltransferase and Histone Deacetylase Inhibitors in the Treatment of Myelodysplastic Syndromes

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2006English

Nucleophosmin Mutations in Acute Myeloid Leukemia in Children

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy